Nadziakiewicz Paweł, Grochla Marek, Krauchuk Alena, Szyguła-Jurkiewicz Bożena, Cymerys Marcin, Zembala Michał O, Przybyłowski Piotr
Department of Cardiac Anesthesia and Intensive Therapy, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland.
Department of Cardiac Anesthesia and Intensive Therapy, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland.
Transplant Proc. 2020 Sep;52(7):2091-2093. doi: 10.1016/j.transproceed.2020.02.102. Epub 2020 Mar 25.
Recipients of nonrenal organ transplants, including the heart, are at risk for developing acute kidney injury (AKI). This situation significantly jeopardized the outcome of patients. The most effective treatment is continuous renal replacement therapy (CRRT) AIM: The goal of this project is to verify the prognostic value of preoperative serum creatinine concentration and glomerular filtration rate (GFR), calculated by the Modification of Diet in Renal Disease formula, to determine the risk of renal failure after grafting RESULTS: In the group of 39 patients, CRRT was needed in 7 patients (17.9%; group K); 32 patients were in the control group (group C). The pretransplant creatinine level in group K was 133.7 ± 31.3 μmol/L and in group C was 160.8 ± 97.6 μmol/L; P = .47. We did not find a difference between groups in GFR: group K 51 ± 6mL/min/1.73 m versus group C 43 ± 20 mL/min/1.73 m; P = .65. Demographic data differed between groups. Patients in group C had significantly more often hypertension, diabetes mellitus, ischemic cardiomyopathy, and previous neurologic disorders and were male. Patients with CRRT had longer intensive care unit (ICU) stays after transplantation than the control population: 25 ± 19 versus 12 ± 10 days; P = .02. Other results showed that primary graft dysfunction occurred in 2 patients in group K and 6 in the control group; 1 needed extracorporeal membrane oxygenation support, and he died on the 12th day. The mean duration of renal replacement therapy was 9.8 days. There were 2 neurologic disorders-1 in each group-and 6 reoperations due to bleeding.
Developing AKI requiring CRRT after heart transplantation prolonged the length of ICU stays. Preoperative creatinine concentration and glomerular filtration rate do not predict AKI.
包括心脏移植在内的非肾器官移植受者有发生急性肾损伤(AKI)的风险。这种情况严重危及患者的预后。最有效的治疗方法是持续肾脏替代治疗(CRRT)。
本项目的目标是验证术前血清肌酐浓度和根据肾脏病饮食改良公式计算的肾小球滤过率(GFR)对确定移植后肾衰竭风险的预后价值。
在39例患者中,7例(17.9%;K组)需要CRRT;32例患者在对照组(C组)。K组移植前肌酐水平为133.7±31.3μmol/L,C组为160.8±97.6μmol/L;P = 0.47。我们未发现两组GFR有差异:K组为51±6mL/min/1.73m²,C组为43±20mL/min/1.73m²;P = 0.65。两组的人口统计学数据不同。C组患者高血压、糖尿病、缺血性心肌病和既往神经系统疾病的发生率明显更高,且男性居多。需要CRRT的患者移植后在重症监护病房(ICU)的住院时间比对照组更长:25±19天对12±10天;P = 0.02。其他结果显示,K组有2例发生原发性移植物功能障碍,对照组有6例;1例需要体外膜肺氧合支持,于第12天死亡。肾脏替代治疗的平均持续时间为9.8天。有2例神经系统疾病,每组各1例,因出血进行了6次再次手术。
心脏移植后发生需要CRRT的AKI会延长ICU住院时间。术前肌酐浓度和肾小球滤过率不能预测AKI。